United States Congress News Advisory concerning February 27 news conference

TEXT OF UNITED STATES CONGRESS NEWS ADVISORY
	Attention:	National reporters / business reporters / health reporters
WASHINGTON -- February 25, 2003 - GlaxoSmithKline legislation: Members of Congress, state and national senior organizations, and health care advocates will hold a news conference Thursday, February 27, in support of legislation to prevent pharmaceutical companies from cutting off American patients buying medicines from Canadian pharmacies. The legislation, called the "Preserving Access to Safe, Affordable Canadian Medicines Act of 2003" (H.R. 847), would subject drug companies to civil money penalties up to $1 million if they discriminate against U.S. consumers who are accessing cheaper prescription drugs from Canada. The tri-partisan legislation, which has 33 original co-sponsors, including Rep. Sanders (I-VT), Rep. Burton (R-IN), Rep. Crowley (D-NY) and Rep. Emerson (R-MO) is in direct response to GlaxoSmithKline's recent move to cut off American patients buying medicines from Canadian pharmacies.
	What:	News conference
	Date:	Thursday, February 27, 2003
	Time:	12:00 p.m
	Place:	Room HC-9, the U.S. Capitol, Washington, D.C.
	Who:	Rep. Bernie Sanders, Rep. Dan Burton, Rep. Joe Crowley, and other Members of Congress, senior organizations and health care advocates.
	Re:	Announcing the introduction of legislation to prevent pharmaceutical companies from cutting off American patients buying medicines from Canadian pharmacies.
	Contact:	Joel Barkin (Rep. Bernie Sanders) (202) 225-411 Suzanne Anziska (Rep. Joe Crowley) (202) 225-3965
Top of the Page